INTEGRA LIFESCIENCES HOLDINGS CORP Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $7.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $7.10M, a 136.67% increase from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $3.00M, a 7.14% increase from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $2.80M.
- INTEGRA LIFESCIENCES HOLDINGS CORP valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2012 was $500.00K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $7.10M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $3.00M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $2.80M 10-K · filed 2025-02-25 | |
| 2013-12-31 | $500.00K 8-K · filed 2014-06-20 | |
| 2012-12-31 | $500.00K 10-K · filed 2015-02-27 | $300.00K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |